2017 BOD Election
rule
Dear Radiosurgery Society Members,

The following seven members were nominated to fill four open seats on the Radiosurgery Society Board of Directors (BOD). On February 1, 2017, ballots were emailed to all Radiosurgery Society members in good standing. The election will end on March 14, 2017 at 5:59pm. If you did not receive your ballot please contact us.

The candidates are:

Stanley H. Benedict, MS, PhD

Dr. Stanley Benedict received his PhD in biomedical physics from UCLA and holds a certification in radiological therapeutic physics from the American Board of Radiology. Dr. Benedict is currently the Professor and Vice Chair of Clinical Physics at Davis, in Sacramento, CA, where he is responsible for supervising physics, dosimetry, and clinical engineering activities of the faculty and staff. Dr. Benedict is a principal investigator and co-investigator on several public and industry funded clinical medical physics research projects, and author of papers focused on image-guided radiation therapy, stereotactic radiosurgery and radiation biology. Dr. Benedict was the chair of the AAPM Recommendations on SBRT (TG101), and he remains very active in stereotactic radiosurgery by participating in clinical trial development and by organizing courses and symposia on SRS/SRT/SBRT.

Hale Basak Özkök Çaglar, MD

Hale Basak Özkök Çaglar is an Associate Professor of Radiation Oncology and head of the department at Medipol University Hospital, Istanbul, Turkey. From 1998 – 2006 she worked in the Gamma Knife Unit of the neurosurgery department at Marmara University, the first Gamma Knife site in Turkey. During her fellowship at Brigham and Women’s Hospital and Dana Farber Cancer Institute, Harvard University in Boston, she worked in thoracic and head and neck oncology and was introduced to and worked with Novalis. Upon her return to Turkey she focused on neuro-oncology, Gamma Knife, thoracic oncology and pediatric tumors. In 2010 while at Acibadem University and Acibadem Maslak Hospital, Istanbul Dr. Caglar was introduced to the CyberKnife and Trilogy Linac. In late 2012 she became the director of Medipol University Hospital Radiation Oncology Department and Gamma Knife Unit with neurosurgery.

Andrew Gaya, BSc, MD, MRCP, FRCR


Andy Gaya gained his MD in London, England in 1995, where he was awarded a distinction and several academic prizes. Dr. Gaya treats gastrointestinal tumours using chemotherapy, radiotherapy, immunotherapy and biological therapies. His dual specialty training in medical and radiation oncology gives him a very balanced perspective into the multimodality nature of modern cancer therapy. His major academic interests are in the areas of functional cancer imaging, immunotherapy and stereotactic body radiotherapy. He has been at the forefront of the implementation of the latest radiotherapy techniques in the UK. He was one of the first UK doctors to use both CyberKnife and Tomotherapy, and is co-editing a major textbook of stereotactic radiotherapy. Dr. Gaya is a Consultant Clinical Oncologist at Guy's & St Thomas' NHS Foundation Trust and the London Oncology Clinic. He joined the RSS board in January 2014.

Peter C. Gerszten, MD, MPH, FACS


Peter C. Gerszten, MD, MPH, FACS is the Peter E. Sheptak Professor of Neurosurgery at the University of Pittsburgh. Dr. Gerszten joined the Department of Neurological Surgery and the UPMC Spine Services Division in 1999. He completed his medical degree at the Johns Hopkins School of Medicine and completed his residency in neurological surgery at the University of Pittsburgh Medical Center. Dr. Gerszten obtained a master of public health degree from the University of Pittsburgh Graduate School of Public Health. He completed a fellowship in spinal surgery at the University of Pittsburgh Medical Center.

Dr. Gerszten specializes in disorders of the spine, focusing on spinal neoplasms. His clinical interests include minimally invasive approaches to the treatment of spinal disorders and spinal tumors. Dr. Gerszten's area of research is the application of outcomes research to spinal surgical interventions. He is a pioneer in the field of spine radiosurgery and oversees the instruction of this developing area of neurosurgery for the American Association of Neurological Surgery.

Gordon Li, MD


Gordon Li, MD is an associate professor of Neurosurgery and, by courtesy, of Neurology and of Otolaryngology Head and Neck Surgery at the Stanford University Medical Center. He is certified by the Board of Neurological Surgery. Dr Li. received his medical degree from the University of California Davis, California in 2004. Both his internship and residency were done Stanford University. Dr. Li’s clinical focuses are: Cancer-Neuro Oncology, neurosurgery, brain tumors, radiosurgery and minimally invasive surgical procedures. In the laboratory he studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials. Clinically, his interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery.

Anand Mahdevan, MD


Anand Mahadevan, MD completed his general surgical and oncology residency in the United Kingdom followed by a fellowship at Beth Israel Deaconess Medical Center (BIDMC) in the Harvard Radiation Oncology Program (HROP). He is currently Chair of the department of Radiation Oncology at Geisinger Health Systems in Danville, Pennsylvania. Other than CNS malignancies, Dr. Mahadevan has had a particular interest in SBRT for liver/pancreas tumors and oligometastases. Anand joined the Board in 2012 and currently serves as the Chairman of the Board of Directors.

Ben J. Slotman, MD, PhD

Ben J. Slotman received his MD (1985) and PhD (1990) both cum laude at the VU University in Amsterdam, The Netherlands. He was registered as radiation oncologist in 1994. In 1998 he was appointed full professor of Radiation Oncology and Chair of the department at VU University. Since 2005 he is also chairman of one of the six divisions of the university medical center. He is co-chair of the Cancer Center Amsterdam (VUMC CCA). Ben Slotman is also board member of the International Society of Radiosurgery (ISRS) and president-elect of the American Radium Society. He has (co)-authored about 300 peer-reviewed publications and coordinated a number of trials, including the EORTC study on PCI in ES-SCLC and the C-REST trial on the role of thoracic irradiation in these patients. His further research activities are concentrated on intra- and extracranial stereotactic radiotherapy and the introduction of new technologies in radiotherapy, most recently stereotactic MRI-guided and adaptive radiotherapy (SMART). Professor Slotman joined the RSS Board of Directors in February 2016.

Member login  
rule

ABSTRACT SUBMISSION DEADLINE
Saturday, April 1, 2017



   
the RSS would like to
acknowledge and thank our 
Corporate Sponsors.

    

the RSS would like to 
acknowledge and thank our 
Academic & Hospital and
Free-Standing & Private Practice
Sponsors.






  
the RSS is pleased to collaborate with the following:







Interact With Us!
facebook Like our Facebook Page   
Join our Facebook Group
twiter Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus
Skype Me™!  Call us on Skype
divider